超越聚合:神经退行性疾病的病理阶段过渡
Cécile Mathieu1, Rohit V Pappu2,3, J Paul Taylor4
1Howard Hughes Medical Institute, Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
概括
细胞阶段过渡对于组织至关重要, 但它们的缺陷导致神经退行性疾病. 了解这些异常转变可以为恢复细胞功能提供治疗点.
科学领域:
- 细胞生物学
- 神经科学
- 生物化学
背景情况:
- 细胞组织依赖于相变,这是细胞功能的一个基本过程.
- 这些阶段过渡的异常越来越被认为是神经退行性疾病发病的早期事件.
研究的目的:
- 审查将阶段过渡缺陷与神经退行相关的证据.
- 阐明病理阶段过渡的机制及其后果.
主要方法:
- 对细胞组织和神经退行现有文献的审查.
- 在蛋白质和凝结物水平上的缺陷分析.
- 讨论一些关键概念,比如动态停止和异型缓冲.
主要成果:
- 蛋白质和多组分凝聚物相变的缺陷与神经退行有关.
- 动态停止和异型缓冲解释了细胞功能障碍和蛋白质沉积的形成.
- 病理阶段过渡有助于增生细胞缺陷.
结论:
- 了解异常阶段过渡是神经退行性疾病病因的关键.
- 这些见解可以指导开发新的治疗策略.
- 通过有针对性的干预恢复细胞平衡是一种有前途的治疗途径.
相关概念视频
Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K
Amyloid Fibrils
6.1K
6.1K
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Neural Regulation
42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K
The Proteasome
1.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K


